Dasatinib Impurity 4 | CAS 1184919-23-0 - Request Quote
Dasatinib Impurity 4
| SZ CAT No: | SZ-D018012 |
| CAS No | 1184919-23-0 |
| Mol.F. | C22H27N7O2S |
| Mol.Wt. | 453.6 |
| Inv. Status | Limited Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dasatinib Impurity 4 is chemically 2-((6-(4-(2-Hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(o-tolyl)thiazole-5-carboxamide. Dasatinib Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Dasatinib Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dasatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1184919-23-0
Purchase 1184919-23-0
Order 1184919-23-0
Enquire 1184919-23-0
price of 1184919-23-0
1184919-23-0 Supplier
1184919-23-0 Manufacturer
1184919-23-0 Exporter
buy high quality Dasatinib Impurity 4
Purchase Dasatinib Impurity 4
Dasatinib Impurity 4 suppliers
Dasatinib Impurity 4 manufacturers
Dasatinib Impurity 4 price
Order Dasatinib Impurity 4
Enquire Dasatinib Impurity 4
Dasatinib Impurity 4 cost
Dasatinib Impurity 4 Supplier
Dasatinib Impurity 4 Distributor
Dasatinib Impurity 4 for Method Validation
Dasatinib Reference Standard
Dasatinib Impurity 4 for ANDA Filing
Dasatinib Impurity 4 for Forced Degradation Studies
Dasatinib Impurity 4 Identification Standards
Dasatinib Impurity 4 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


